Skip to main content
. 2021 Nov 6;2021(11):CD001800. doi: 10.1002/14651858.CD001800.pub4

8. Results of univariate meta‐regression for all‐cause hospitalisation.

Explanatory variable (n trials) Exp (slope)* 95% confidence interval,P value Proportion of variance explained
(adjusted R2)
Interpretation
Case mix (% MI patients) (n = 23) RR = 1.00 1.00 to 1.01, P = 0.71 ‐20.91% No evidence that risk ratio is associated with case mix
Dose of exercise (number of weeks of exercise training x average number of sessions/week x average min/session) (n = 19) RR = 1.00 1.00 to 1.00, P = 0.44 ‐69.78% No evidence that risk ratio is associated with dose of exercise
Duration of follow‐up (months) (n = 23) RR = 1.01 1.00 to 1.01, P = 0.07 56.52% No evidence that risk ratio is associated with length of follow‐up
Type of CR (exercise only vs comprehensive CR) (n = 23) RR = 0.93 0.65 to 1.33, P = 0.70 ‐50.20% No evidence that risk ratio is associated with type of CR
Year of publication (pre‐1995 vs post‐1995) (n = 23) RR = 1.12 0.80 to 1.57, P = 0.48 ‐32.69% No evidence that risk ratio is associated with publication year
Setting (centre vs home) (n = 23) RR = 0.94 0.83 to 1.06, P = 0.28 ‐36.70% No evidence that risk ratio is associated with setting of CR
Risk of bias (low risk in ≤ 3 items vs > 3 items) (n = 23) RR = 1.00 0.71 to 1.40, P = 0.99 ‐44.14% No evidence that risk ratio is associated with risk of bias
Study location (continent ‐ Europe, North America, Australia/Asia or Other) (n = 23) RR = 0.86 0.69 to 1.08, P = 0.18 ‐137.18% No evidence that risk ratio is associated with study location
Low‐ and middle‐income country (LMIC) vs high income country (n = 23) RR = 1.06 0.72 to 1.55, P = 0.76 ‐49.12% No evidence that risk ratio is associated with LMIC
Sample size (≤ 150 vs > 150) (n = 19) RR = 1.45 1.08 to 1.96, P = 0.02 100% No evidence that risk ratio is associated with study sample size